Sn Surgicare & Healthcare Science Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 10-12-2024
- Paid Up Capital ₹ 4.00 M
as on 10-12-2024
- Company Age 15 Year, 10 Months
- Last Filing with ROC 31 Mar 2018
- Open Charges ₹ 2.00 Cr
as on 10-12-2024
- Satisfied Charges ₹ 9.75 M
as on 10-12-2024
- Revenue 0.65%
(FY 2018)
- Profit 4.96%
(FY 2018)
- Ebitda -9.12%
(FY 2018)
- Net Worth 11.91%
(FY 2018)
- Total Assets 2.23%
(FY 2018)
About Sn Surgicare & Healthcare Science
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 4.00 M.
The company currently has active open charges totaling ₹2.00 Cr. The company has closed loans amounting to ₹9.75 M, as per Ministry of Corporate Affairs (MCA) records.
Sukhendu Nag and Alakananda Nag serve as directors at the Company.
- CIN/LLPIN
U85100WB2009PTC132933
- Company No.
132933
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Feb 2009
- Date of AGM
30 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
24 Parganas, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sn Surgicare & Healthcare Science?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sukhendu Nag  | Director | 19-Feb-2009 | Current |
| Alakananda Nag | Director | 19-Feb-2009 | Current |
Financial Performance of Sn Surgicare & Healthcare Science.
Sn Surgicare & Healthcare Science Private Limited, for the financial year ended 2018, experienced modest growth in revenue, with a 0.65% increase. The company also saw a slight improvement in profitability, with a 4.96% increase in profit. The company's net worth Soared by an impressive increase of 11.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sn Surgicare & Healthcare Science?
In 2018, Sn Surgicare & Healthcare Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Mar 2018 | ₹2.00 Cr | Open |
United Bank Of India Creation Date: 26 Mar 2011 | ₹9.75 M | Satisfied |
How Many Employees Work at Sn Surgicare & Healthcare Science?
Unlock and access historical data on people associated with Sn Surgicare & Healthcare Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sn Surgicare & Healthcare Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sn Surgicare & Healthcare Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
